MEKanistic Therapeutics
Phase 1Developing a novel category of precision medicines that offer targeted and long-lasting benefits for cancer patients.
Founded
2021
Focus
Small Molecules
About
Developing a novel category of precision medicines that offer targeted and long-lasting benefits for cancer patients.
Funding History
2Total raised: $30M
Series A$25MUndisclosedFeb 15, 2023
Seed$5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile